title: Portal vein thrombosis in systemic lupus erythematosus associated with anticardiolipin antibodies.
authors.forename: Javier A
authors.initials: JA
authors.lastname: Cavallasca
authors.forename: Jorge L
authors.initials: JL
authors.lastname: Musuruana
authors.forename: Gonzalo
authors.initials: G
authors.lastname: Granero
mesh_terms: D000328:Adult; D017153:Antibodies, Anticardiolipin / Q000097:blood* / Q000276:immunology; D000925:Anticoagulants / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000150:complications / Q000473:pathology / Q000628:therapy; D003131:Combined Modality Therapy; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D011169:Portal Vein / Q000473:pathology; D011433:Propranolol / Q000627:therapeutic use; D002583:Uterine Cervical Neoplasms / Q000150:complications / Q000473:pathology / Q000628:therapy; D020246:Venous Thrombosis / Q000150:complications / Q000188:drug therapy / Q000473:pathology*
chemical_list: D017153:Antibodies, Anticardiolipin; D000925:Anticoagulants; D018501:Antirheumatic Agents; D011433:Propranolol